BANGKOK, Dec. 2, 2025 -- The Faculty of Medicine, Chulalongkorn University, in collaboration with the Faculty of Engineering, has developed "Deep GI," an artificial intelligence (AI) innovation designed to assist doctors in detecting gastrointestinal cancers with high standard performance equal to that of expert specialists. Trained on hundreds of thousands of endoscopic images, the system has received the Thai FDA approval and is being prepared for national deployment and startup commercialization. Colorectal cancer remains the third most common cancer among Thais, a
SEOUL, South Korea, Dec. 2, 2025 -- Leaders Dental Laboratory (branded globally as LEADERS DENTAL), a leading digital dental laboratory in Korea, is rapidly strengthening its presence in the global digital dentistry market with its flagship product, the surgical guide. Backed by recent export achievements in five countries—including the United Kingdom, Japan, and Taiwan—the company is expanding exports of its integrated digital solution packages to align with the global shift from single implant components to fully systemized workflows. LEADERS DENTAL operates a large-scale digital man
SEOUL, South Korea, Dec. 2, 2025 -- Suchang a Korean manufacturer specializing in over 150 types of natural bio-based ingredients and overseas distribution consulting, announced that it has successfully developed a new dog food product using gamgyul-bak—by-products from Jeju's citrus processing industry. Tentatively branded as "Orange Dogs," the new product is designed for global markets, with export plans targeting the United States, Japan, China, and Europe. Originally operating as a B2B-focused bio-raw material manufacturer, Suchang has launched the "Orange Dogs"
HANGZHOU, China and SHANGHAI and BOSTON, Dec. 2, 2025 -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on developing innovative therapies for immune and inflammatory diseases, today announced that its innovative TYK2 allosteric inhibitor, LNK01006, has been approved by U.S. Food and Drug Administration (FDA) for human clinical trials. LNK01006 is a highly brain-penetrant, potent, and selective oral TYK2 allosteric inhibitor targeting the JH2 domain. TYK2 is a key regulator of th
LYON, France, Dec. 2, 2025 -- NEJM Evidence, a journal of the New England Journal of Medicine Group, has published an article titled "Validation of a Saliva microRNA Signature for Endometriosis," dedicated to the saliva-based diagnostic test developed by Ziwig. The publication reports the results of a prospective, independent, multicenter clinical study conducted in France. The study enrolled 971 symptomatic women aged 18 to 43 years across 17 public and private hospitals. High-performance saliva-based diagnosis The Ziwig Endotest® was evaluated thro
SYDNEY, Dec. 2, 2025 -- Miroma Project Factory (MPF) was delighted to welcome Westmead Fertility Centre to the agency fold for a wide-reaching digital transformation initiative. The engagement began with a comprehensive audit of Westmead Fertility Centre's digital infrastructure to identify opportunities across systems, tools, and platforms to deliver a truly patient-focused experience. This discovery phase included detailed user and stakeholder research, which has informed a robust patient-led digital transformation. Spearheaded by MPF's CEO and Technical Strategist, Kat Robinson and her tea
BELLEVUE, Wash., Dec. 2, 2025 -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that management will present at the upcoming Emerging Growth Conference. This presentation will provide investors and analysts with an updated overview of OSR Holdings' diversified healthcare platforms and strategic growth initiatives. Virtual Presentation Details Date: December 10, 2025 Time: 9:05 a.m. ET Format: Corporate Overview Registration Link: https://goto.
AVONDALE, Pa., Dec. 2, 2025 -- CQ Medical, the global leader in patient radiotherapy positioning and healthcare innovation, is proud to announce the acquisition of Bionix's Radiation Therapy business unit, marking an expansion of its patient positioning and marking product portfolio. The acquisition reinforces CQ Medical's mission to advance precision in radiotherapy, empowering clinicians and improving outcomes worldwide. Bionix has established a strong reputation of developing innovative, high-quality medical devices across multiple patient care segments for over 40 years. Following
[ 메디채널 김갑성 기자 ] The company brings a full array of technology to its two booths in Chicago, showcasing another year of increasing R&D and investment. CHICAGO, Dec. 2, 2025 -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will showcase a range of cutting-edge technologies at RSNA 2025. Under the theme "Passion for Change, For One and All," the company will highlight how its technology is built to see the uniqueness of each individual and extend access to advanced care across different communities. The portfolio on d
SANTA CLARA, Calif., Dec. 1, 2025 -- The Frost & Sullivan Institute is proud to announce the recipients of the 2025 Visionary Growth Leadership Best Practices Recognition, celebrating organizations that exemplify purpose-driven innovation, sustainable business models, and leadership committed to creating a positive global impact. This recognition highlights the companies that are spearheading meaningful change and addressing the global priorities identified by the Frost & Sullivan Institute. "The Visionary Growth Leadership Best Practices Recognition celebrates companies t